Number-needed-to-treat analysis of clinical progression in patients with metastatic castration-resistant prostate cancer in the STRIVE and TERRAIN trials

BACKGROUND: This analysis estimated the number needed to treat with enzalutamide versus bicalutamide to achieve one additional patient with chemotherapy-naïve metastatic castration-resistant prostate cancer who would obtain clinical benefit regarding progression-free survival, radiographic progressi...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:BMC Urol
Main Authors: Schultz, Neil M., Shore, Neal D., Chowdhury, Simon, Klotz, Laurence H., Concepcion, Raoul S., Penson, David F., Karsh, Lawrence I., Yang, Hongbo, Brown, Bruce A., Barlev, Arie, Flanders, Scott C.
Formato: Artigo
Idioma:Inglês
Publicado em: BioMed Central 2018
Assuntos:
Research Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6128000/
https://ncbi.nlm.nih.gov/pubmed/30189902
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12894-018-0387-7
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados